Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hemophilia A

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hemophilia A:

Pubmed Logo
[Hemophilic pseudotumor: a report of 1 case]
Summary Background: Approximately 25% of severe hemophilia A (HA) patients...
13th November, 2009
Radiology Department, the 251st PLA Hospital, Zhangliakou 075000, Hebei, Zhongguo Gu Shang. 2009 Sep;22(9):720.
No more Doritos and lobster tails: a case report of life-threatening sublingual hematoma.
This case report highlights a life-threatening complication of mild...
12th November, 2009
Department of Emergency Medicine and Internal Medicine, Aria helth, Del Med J. 2009 Jul;81(7):255-8.
Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIII.
Replacement therapy with exogenous factor VIII (FVIII) to treat...
6th November, 2009
INSERM, UMR S 872, Paris, France; Blood. 2009 Nov 4.
DOI Direct Link
Effects of electrical stimulation on muscle trophism in patients with hemophilic arthropathy.
OBJECTIVE: To determine changes occurring in the cross-sectional area,...
6th November, 2009
Area of Physical Education and Sports, Miguel Hernandez University, Elche, Arch Phys Med Rehabil. 2009 Nov;90(11):1924-30.
DOI Direct Link
Evolution of recombinant factor VIII safety: KOGENATE((R)) and Kogenate ((R)) FS/Bayer.
The use of factor VIII (FVIII) concentrates in the treatment of hemophilia...
3rd November, 2009
Hemophilia and Hemostasis Program, Children's Hospital of Michigan, Int J Hematol. 2009 Nov 3.
DOI Direct Link

View more research publications.

Press Releases About Hemophilia A:

BioPortfolio Logo
AMT Provides Business Update for the Third Quarter 2009 18th November, 2009
AMSTERDAM, November 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in
These Patients Need Your Help This Thanksgiving 17th November, 2009 New York Blood Center
NEW YORK, Nov. 17 /PRNewswire-USNewswire/ -- As we approach Thanksgiving, "Black Friday" and the holiday season, New York Blood Center (NYBC) calls upon the community to please remember the
Diplomat Specialty Pharmacy Continues to Expand - Opens Location in Southern California 17th November, 2009 Diplomat Specialty Pharmacy
SWARTZ CREEK, Mich., Nov. 17 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today the opening of their branch in San Bernardino, CA. Diplomat has 6 additional locations in Michigan, Ohio,
World Champion New York Yankees, BNY Mellon to be Honored as New York Blood Center 'Champions of Life' 15th November, 2009 New York Blood Center
NEW YORK, Nov. 15 /PRNewswire/ -- The World Champion New York Yankees and BNY Mellon will be honored as "Champions of Life" at New York Blood Center's (NYBC) Biennial Chairman's
Community Blood Drives Benefit Cancer Patients 30th October, 2009 New York Blood Center
NEW YORK, Oct. 30 /PRNewswire-USNewswire/ -- November is both Pancreatic Cancer Awareness Month and Lung Cancer Awareness Month, and New York Blood Center (NYBC) and its divisions in Manhattan, Long

BioNews Results for Hemophilia A:

RSS Logo
BioPortfolio Logo
FDA Approves New Drug For Heavy Menstrual Bleeding
WJAC TV:  Nov 14 2009 8:19AM Matching: hemophilia
FDA approves new drug for heavy menstrual bleeding
Charlotte Observer:  Nov 14 2009 7:47AM Matching: hemophilia
FDA approves new drug for heavy menstrual bleeding
Anderson Independent-Mail:  Nov 14 2009 6:42AM Matching: hemophilia
FDA approves new drug for heavy menstrual bleeding
Daily Advance:  Nov 14 2009 6:18AM Matching: hemophilia
Maxygen Buying Back Stock; Analysts Say No Trend Here
BioWorld:  Nov 14 2009 6:06AM Matching: hemophilia
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Hemophilia A Clinical Trials:

Clinical Trials Logo
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients

Hemophilia A Patents:

USPTO Logo
US Patent No.Title
7563459 Methods and compositions for regenerating tissue
7576065 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
7576181 Method of administering porcine B-domainless fVIII
7576186 Compositions and methods for stem cell delivery
7576189 Antibodies to human vascular endothelial growth factor 2 and methods of using the same

View more patents.

Companies working in the area of Hemophilia A from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Transkaryotic Therapies Incorporated RKT

Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies. TKT develops, and intends to commercialize, protein...
www.tktx.com/        View full profile
Thumbshot

The Comprehensive Bleeding Disorders Center (CBDC)

The Comprehensive Bleeding Disorders Center (CBDC) was incorporated as a not-for-profit organization in 1996, established specifically to serve people with bleeding disorders. CBDC is the only center...
www.hemophilia-ctr-peoria.com/        View full profile
Thumbshot

ZLB Behring LLC

ZLB Behring is one of the world’s leading pharmaceutical companies specializing in the manufacture of plasma products. Its comprehensive line of therapies include products for the treatment of...
www.zlb.com/        View full profile
Thumbshot

View more Hemophilia A related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Hemophilia A scientists - we have details of around 1459 individuals working on Hemophilia A .


This page has been viewed 312 times
Recent Search Terms used to find this page: Improvement of I-PCR and its application in gene diagnosis of hemophilia A | Improvement of I-PCR and its application in gene diagnosis of hemophilia A | Pharmaceutical companies working on hemophilia | list of hemophilia product companies | Kogenate lip | PEG-Lip bayer healthcare LLC | PEG-Lip bayer healthcare LLC | A review of current literature on second-generation sucrose-formulated full-length recombinant factor VIII | A review of current literature on second-generation sucrose-formulated full-length recombinant factor VIII | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hemophilia A across BioPortfolio, or for Hemophilia A Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.